Vaxxinity (VAXX) Earnings Date, Estimates & Call Transcripts → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free VAXX Stock Alerts $0.12 -0.01 (-8.47%) (As of 10:45 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Mar. 27) -$0.09 Beat By $0.04 Consensus EPS (Mar. 27) -$0.13 Get Vaxxinity Earnings AlertsEnter your email address below to receive the latest news and earnings results for VAXX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVAXX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VAXX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> VAXX Earnings Date and InformationVaxxinity last released its quarterly earnings data on March 27th, 2024. The reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.04. Vaxxinity has generated ($0.45) earnings per share over the last year (($0.45) diluted earnings per share). Vaxxinity has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Vaxxinity Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 3/27/2024Q4 2023($0.13)($0.09)+$0.04($0.09)--11/8/2023Q3 2023($0.14)($0.10)+$0.04($0.10)--8/9/2023Q2 2023($0.16)($0.11)+$0.05($0.11)--5/9/2023Q1 2023($0.16)($0.15)+$0.01($0.15)--3/27/2023Q4 2022($0.16)($0.16)-($0.16)--11/10/2022Q3 2022($0.16)($0.15)+$0.01($0.15)-- Get the Latest News and Ratings for VAXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.38)($0.14)+$0.24($0.14)--5/9/2022Q1 2022($0.34)($0.31)+$0.03($0.15)-$0.02 million3/24/2022Q4 2021($0.35)($0.48)($0.13)($0.48)--12/22/2021Q3 2021($0.12)($0.24)($0.12)($0.44)-$0.05 million Vaxxinity Earnings - Frequently Asked Questions When is Vaxxinity's earnings date? Vaxxinity has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on VAXX's earnings history. Did Vaxxinity beat their earnings estimates last quarter? In the previous quarter, Vaxxinity (NASDAQ:VAXX) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.13) by $0.04. Learn more on analysts' earnings estimate vs. VAXX's actual earnings. How much revenue does Vaxxinity generate each year? Vaxxinity (NASDAQ:VAXX) has a recorded annual revenue of $70,000.00. How much profit does Vaxxinity generate each year? Vaxxinity (NASDAQ:VAXX) has a recorded net income of -$56.93 million. VAXX has generated -$0.45 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: AYTU Earnings Date TNXP Earnings Date HUGE Earnings Date COCP Earnings Date NRBO Earnings Date VBIV Earnings Date NERV Earnings Date PIRS Earnings Date EDSA Earnings Date NNVC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:VAXX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
